International Cancer Genome Consortium (ICGC) Canada
Research
Date range: 1 January 2023 - 31 December 2023
Research collaboration: International Cancer Genome Consortium (ICGC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
International Cancer Genome Consortium (ICGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Cancer Research UK (CRUK)
- Carlos Slim Health Institute
- Chinese Cancer Genome Consortium (CCGC)
- Department of Biotechnology (DBT)
- FP7 - Finland, EC
- French National Cancer Institute (INCa)
- Genome Canada
- German Aerospace Center (DLR)
- German Cancer Aid (DKH)
- German Federal Ministry of Education and Research (BMBF)
- Japan Agency for Medical Research and Development (AMED)
- King Faisal Specialist Hospital and Research Centre (KFSH&RC)
- Korea Research Institute of Bioscience and Biotechnology (KRIBB)
- NIH National Cancer Institute (NCI)
- NIH National Human Genome Research Institute (NHGRI)
- National Cancer Center (NCC)
- National Health and Medical Research Council (NHMRC)
- Ontario Institute for Cancer Research (OICR)
- Prostate Cancer Canada (PCC)
- Spain Ministry of Science, Innovation and Universities (MICINN)
- University of Glasgow
- University of Verona (UNIVR)
- Wellcome Sanger Institute
- Wellcome Trust